Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year. 

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2019

2018

% Change

2018

2017

2016

2015

2014

Acute Flaccid Myelitis

0

--

--

--

--

--

--

--

Anthrax

0

0

--

0^

0

0

0

0

Arboviral Diseases (excludes Chikungunya virus, Dengue, and Zika virus)

4

27

-85.2%

28

62

18^

9^

4^

Babesiosis

0

0

--

0

1

0

2

1

Botulism

1

0

--

0

0

1

1

0

Brucellosis

4

1

300.0%

1

0

0

2

0

Campylobacteriosis

609

642

-5.1%

783

790

692

589^

255

Chikungunya virus

0

0

--

0

1

1^

1^

19^

Cholera

0

0

--

0

0

0

0

0

Coccidioidomycosis

6

--

--

--

--

--

--

--

Cryptosporidiosis

175

132

32.6%

152

189

334

261

147

Cyclosporiasis

5

--

--

--

--

--

--

--

Dengue

3

2

50.0%

3

0

5

3^

3

E. coli, shiga toxin-producing (includes O157: H7)

109

115

-5.2%

129^

31

39

40

41^

Ehrlichiosis/Anaplasmosis

37

21

76.2%

24

17

21

18

19

Giardiasis

126

193

-34.7%

217

191

234

188

182

Hansen's Disease (Leprosy)

0

0

--

0

1

1

1

0

Hantavirus Pulmonary Syndrome

0

--

--

--

--

--

--

--

Hemolytic uremic syndrome (HUS)

6

1

500.0%

3

0

6

3

1

Hepatitis E, acute

0

0

--

0

0

0

0

0

Influenza-associated non-pediatric mortality

89

186

-52.2%

257

--

--

--

--

Influenza-associated pediatric mortality

1

2

-50.0%

2

1

0

1

1

Legionellosis

57

62

-8.1%

76

66

63

59

62

Leptospirosis

0

1

-100.0%

1

0

0

0

1

Listeriosis

6

10

-40.0%

11

5

8

5

9

Lyme disease

47

29

62.1%

36

39^

38

25

17

Malaria

6

8

-25.0%

9

8

10

11

13^

Novel Influenza A virus infection

0

0

--

0

0

0

0

0^

Paratyphoid Fever

0^

6^

-100.0%

6^

3

9

0

0

Plague

0

0

--

0

0

0

0

0

Psittacosis

0

0

--

0

0

0

0

0

Q fever

2

2

0.0%

2

0

1

0

2

Rabies, animal

42

51

-17.6%

55

51

77

83

78

Rabies, human

0

0

--

0

0

0

0

0

Salmonellosis

789

977^

-19.2%

1198^

1129^

1276

1151

1165

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0

0

--

0

0

0

0

0

Shigellosis

232

249

-6.8%

320

247^

239

680

516

Smallpox

0

0

--

0

0

0

0

0

Spotted Fever Rickettsiosis

417

621

-32.9%

673

671

453

288

220

Toxic Shock Syndrome (non-streptococcal)

0

--

--

--

--

--

--

--

Trichinellosis (Trichinosis)

0

0

--

0

0

0

0

0^

Tularemia

4

0

--

0

1^

1

0

0

Typhoid fever

0^

1

-100.0%

1

1

0

0

2

Vibriosis (non-Cholera)

30

30

0.0%

38

26^

31

19

20

Viral hemorrhagic fever

0

0

--

0

0

0

0

0

VISA (Staphylococcus aureus, vancomycin-intermediate)

0

1

-100.0%

1

4

3

2

2

VRSA (Staphylococcus aureus, vancomycin-resistant)

1

0

--

0

0

0

0

0

Yellow Fever

0^

0

--

0

0

0

0

0

Zika virus

0

3

-100.0%

3

4

41^

0^

0^

Other Investigations

3

0

--

0

0

0

0

27

Total

2811

3373

-16.7%

4029

3539

3602

3442

2807

NOTE: Counts include finalized investigations among Alabama residents as of October 24, 2019. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*Through MMWR Week 42 (week ending October 19, 2019), as compared to the same time period in the previous calendar year.

^The case definition was updated this year for this condition.

 





Page last updated: October 25, 2019